Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New home program aims to speed recovery for frail seniors after colon cancer surgery

NCT ID NCT06802991

Symptom relief Sponsor: Copenhagen University Hospital at Herlev Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether a special home-based program (ERAS 3.0) can help older, frail patients recover better after colon cancer surgery. The program includes a health check, diet advice, and exercise guidance at home. Sixty participants will be randomly assigned to either the program or standard care, and their recovery will be tracked for three months.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 60 people

The number the study aims to enrol. It can still change while the study runs.

Started

Apr 2025

Expected to finish

Dec 2029

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

65 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age 65+ * Clinical Frailty Scale preoperative score 4-7 * Nutritional Risk Screening tool (NRS 2002) \> 3 * Elective colonic resection * No stoma planned * Minimally invasive surgical approach (laparoscopic or robotic) * Patients discharged to own home * Informed consent to participate Exclusion Criteria: * Stoma creation during index surgery * Conversion to laparotomy * Major complications following surgery (Clavien-Dindo \>3a) * Participation in other randomised trials in conflict with the protocol and end- points of the ERAS 3.0 project * Discharged with tube feeding and parenteral nutrition (partially or completely) * Known food allergies to dairy or any other ingredient contained in the nutrition package * Incapable of providing informed consent * Discharge to 24-hour municipal rehabilitation facility * All conditions including psychological, geographical, and social factors that could hinder adherence to the trial protocol * Neoadjuvant radio- or chemotherapy

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Colon cancer are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

colon carcinoma colonic neoplasm Frailty

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Colon cancer Frailty

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    2 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • University Hospital Herlev

    NOT_YET_RECRUITING

    Herlev, 2730, Denmark

  • University Hospital Herlev

    RECRUITING

    Herlev, 2730, Denmark

More trials for these conditions

Other studies related to the condition(s) this trial covers.